Silo Pharma, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $4.7M | $3.9M | $3.5M | $11.4M | $9.8M | $1.1M | $111.8K | $336.7K |
| Accounts Receivable | — | — | — | $66.0K | — | $23.5K | — | — |
| Inventory | — | — | — | — | $58.4K | $33.5K | $156.4K | $27.0K |
| Total Current Assets | $7.4M | $7.1M | $7.7M | $11.6M | $10.4M | $1.4M | $493.8K | $626.0K |
| Property, Plant & Equipment | — | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $217.4K | $241.2K | — | — | — | — | — | $29.4K |
| Total Assets | $7.6M | $7.4M | $7.7M | $11.6M | $10.5M | $1.4M | $493.8K | $855.4K |
| Liabilities | ||||||||
| Accounts Payable | $578.1K | $1.6M | $703.5K | $364.2K | $417.9K | $127.1K | $54.9K | $25.6K |
| Total Current Liabilities | $650.2K | $1.7M | $775.6K | $436.3K | $490.0K | $141.7K | $116.7K | $48.0K |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $1.3M | $2.4M | $1.6M | $1.3M | $1.4M | $146.0K | $116.7K | $448.0K |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-19.5M | $-15.3M | $-10.9M | $-7.2M | $-3.3M | $-5.8M | $-2.7M | $-1.6M |
| Total Stockholders' Equity | $6.3M | $5.0M | $6.2M | $10.3M | $9.1M | $1.3M | $-22.9K | $407.4K |